| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038820087 |
| P356 | DOI | 10.1186/1755-8794-8-S2-S6 |
| P932 | PMC publication ID | 4460748 |
| P698 | PubMed publication ID | 26043758 |
| P5875 | ResearchGate publication ID | 277779696 |
| P50 | author | Xinan Yang | Q83366108 |
| P2093 | author name string | John M Cunningham | |
| Bin Wang | |||
| P2860 | cites work | Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival. | Q36075250 |
| Text-mining assisted regulatory annotation | Q36642396 | ||
| Therapy-related myeloid leukemia. | Q37009760 | ||
| Dysregulated gene expression networks in human acute myelogenous leukemia stem cells | Q37097180 | ||
| Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming. | Q37189326 | ||
| Finding distal regulatory elements in the human genome | Q37621072 | ||
| Identifying and mitigating bias in next-generation sequencing methods for chromatin biology | Q38249872 | ||
| Transcriptional profiles of unirradiated or UV-irradiated human cells expressing either the cancer-prone XPB/CS allele or the noncancer-prone XPB/TTD allele. | Q38332883 | ||
| Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis. | Q39004667 | ||
| High mobility group box 1 promotes tumor cell migration through epigenetic silencing of semaphorin 3A. | Q39064881 | ||
| Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia | Q39283792 | ||
| The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing. | Q40088699 | ||
| Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization | Q40144602 | ||
| Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers | Q40391221 | ||
| Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. | Q46045890 | ||
| A description of the Molecular Signatures Database (MSigDB) Web site | Q46317320 | ||
| Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase | Q46823363 | ||
| Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease | Q50594569 | ||
| The functional and mechanistic relatedness of EZH2 and menin in hepatocellular carcinoma | Q51515581 | ||
| Stem cell gene expression programs influence clinical outcome in human leukemia. | Q51856192 | ||
| OrderedList--a bioconductor package for detecting similarity in ordered gene lists | Q51937584 | ||
| Statistical Methods for Identifying Differentially Expressed Genes in DNA Microarrays | Q58618312 | ||
| Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring | Q82704793 | ||
| Defining functional DNA elements in the human genome | Q22066251 | ||
| Genomic views of distant-acting enhancers | Q22122210 | ||
| Genome-wide maps of chromatin state in pluripotent and lineage-committed cells | Q24632506 | ||
| The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
| Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells | Q24670084 | ||
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells | Q24672969 | ||
| Statistical significance for genomewide studies | Q24681264 | ||
| Role of histone H3 lysine 27 methylation in Polycomb-group silencing | Q28131795 | ||
| Cis-regulatory elements: molecular mechanisms and evolutionary processes underlying divergence | Q29032100 | ||
| The ENCODE (ENCyclopedia Of DNA Elements) Project | Q29547219 | ||
| Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders | Q29614510 | ||
| The polycomb group protein EZH2 is involved in progression of prostate cancer | Q29614514 | ||
| Distribution and intensity of constraint in mammalian genomic sequence | Q29614574 | ||
| Adjusting batch effects in microarray expression data using empirical Bayes methods | Q29614937 | ||
| Tackling the widespread and critical impact of batch effects in high-throughput data | Q30004214 | ||
| A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 | ||
| Meta-analysis of several gene lists for distinct types of cancer: a simple way to reveal common prognostic markers | Q33268788 | ||
| Global rank-invariant set normalization (GRSN) to reduce systematic distortions in microarray data | Q33389620 | ||
| Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal | Q33463820 | ||
| Mechanism-anchored profiling derived from epigenetic networks predicts outcome in acute lymphoblastic leukemia | Q33504384 | ||
| Identification of protein-coding and non-coding RNA expression profiles in CD34+ and in stromal cells in refractory anemia with ringed sideroblasts | Q33633465 | ||
| Genome wide screen identifies microsatellite markers associated with acute adverse effects following radiotherapy in cancer patients | Q33654687 | ||
| Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. | Q33873844 | ||
| Strategies for aggregating gene expression data: the collapseRows R function | Q33981973 | ||
| Genome-wide quantitative enhancer activity maps identified by STARR-seq | Q34035127 | ||
| Topology of mammalian developmental enhancers and their regulatory landscapes | Q34379841 | ||
| Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. | Q34380411 | ||
| An approach for the identification of targets specific to bone metastasis using cancer genes interactome and gene ontology analysis | Q34482311 | ||
| Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis | Q34637945 | ||
| Overexpressed DNA Polymerase Iota Regulated by JNK/c-Jun Contributes to Hypermutagenesis in Bladder Cancer | Q34902441 | ||
| Altered Hematopoietic Cell Gene Expression Precedes Development of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia and Identifies Patients at Risk | Q35563771 | ||
| Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice | Q35913662 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P304 | page(s) | S6 | |
| P577 | publication date | 2015-05-29 | |
| P1433 | published in | BMC Medical Genomics | Q15754662 |
| P1476 | title | Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: Effective integration of genome-wide histone modification with transcriptional profiles | |
| P478 | volume | 8 Suppl 2 |
Search more.